This page is intended for UK patients who have been prescribed a medication in the Pathway Portfolio Range
I am a UK Patient who has been prescribed Assicco® (glycopyrronium bromide) tablets
By clicking ‘Yes’ you will leave the Pathway Portfolio website and be re-directed to the electronic Medicines Compendium (eMC).
Aspire Pharma is not responsible for the content on external websites.
I am a UK Patient who has been prescribed Biquelle® XL (quetiapine) prolonged-release tablets
I am a UK Patient who has been prescribed Combisal® (salmeterol/fluticasone) pressurised metered dose inhaler (pMDI)
I am a UK Patient who has been prescribed Delofine® XL (felodipine) tablets
By clicking ‘Yes’ you will leave the Pathway Portfolio website and be re-directed to the electronic Medicines Compendium (eMC).
Aspire Pharma is not responsible for the content on external websites.
I am a UK Patient who has been prescribed Dyzantil®▼(sodium valproate) prolonged-release tablets
I am a UK Patient who has been prescribed Gatalin® XL (galantamine) prolonged-release capsules
I am a UK Patient who has been prescribed Neditol® XL (tolterodine) prolonged-release capsules
I am a UK Patient who has been prescribed Repinex® XL (ropinirole) prolonged-release
I am a UK Patient who has been prescribed Sevodyne® (buprenorphine) transdermal patches
I am a UK Patient who has been prescribed Sukkarto® SR (metformin hydrochloride) prolonged-release tablets
By clicking ‘Yes’ you will leave the Pathway Portfolio website and be re-directed to the electronic Medicines Compendium (eMC).
Aspire Pharma is not responsible for the content on external websites.
I am a UK Patient who has been prescribed Vencarm® XL (venlafaxine) prolonged-release capsules
XLW1010311J1_JUN2024
